Search bioRxiv⌕ Search

bioRxiv · 10.64898/2026.10.09.757775

FLEX-DBS: a flexible wireless platform for bilateral constant-current deep brain stimulation in freely moving rodents

Abstract

Background: Preclinical deep brain stimulation (DBS) in rodents is central to understanding how DBS works, but most rodent DBS is delivered through a tether, which constrains behavior, home-cage experiments and uninterrupted stimulation. Most long-runtime wireless mouse stimulators achieve their runtimes by setting stimulation parameters before or around implantation and operating from supplies of about 3 V. New method: FLEX-DBS (Flexible Deep Brain Stimulation) is a head-mounted, battery-powered stimulator that delivers bilateral constant-current stimulation from improved Howland current pumps on +/-5 V rails. Amplitude, pulse width and frequency are programmable in continuous and burst modes from an iOS application over Bluetooth Low Energy, and stimulation continues autonomously after the phone disconnects. The device measures 19.5 x 22.5 x 8.72 mm, weighs 3.71 g in operation and runs on two size-13 zinc-air cells, which are exchanged by briefly detaching the device, pausing stimulation only for the exchange. Results: Into a 1 k{Omega} bench load, delivered current increased approximately linearly with the amplitude setting and was repeatable from pulse to pulse, with an asymmetric biphasic waveform whose recovery phase ran at about one fifth of the stimulating amplitude. Battery current was 1.47-1.89 mA in standby and 3.15-3.42 mA during stimulation at amplitude settings of 60-400 A, giving a projected three days of continuous stimulation per pair of cells. Firmware v0.5 left a net charge of 26-35 % of the stimulating-phase charge per pulse into 1 k{Omega}. Into 47 k{Omega}, within the in vivo load range, stimulating current was compliance-limited at 93 A. Pulse-derived estimates of the effective load presented by five implanted platinum electrodes in three mice had weekly means of 43-54 k{Omega} over eight weeks (32-80 k{Omega} across individual sessions), placing the maximum regulated current near 90 A (81-101 A at the weekly means). Analysis of the current-pump network bounds load-dependent current error at 3-8% for these loads. In vivo, we delivered cingulate FLEX-DBS at high amplitude settings intended to evoke a robust stimulation-associated behavioral phenotype in six mice. Time spent immobile in an open field rose from 46.5% at baseline to 75.7% during stimulation (a 62.7% increase in the group mean) and remained elevated after stimulation ended; without a sham control, this increase cannot be separated from within-session habituation. Comparison with existing methods: Among the published wireless rodent stimulators compared here, several offer some of these capabilities, but none combines bilateral constant current output, real-time wireless control that continues as autonomous stimulation after disconnect, and both continuous and burst modes; FLEX-DBS does so at the cost of runtime measured in days rather than weeks. Conclusions: FLEX-DBS is designed for untethered DBS experiments in which parameters must be set, changed and verified at the cage. Its measured power consumption permits a projected three days of continuous operation per cell pair; firmware v0.5 requires improved charge balancing before prolonged in vivo stimulation. The electrode load, rather than the programmable range, sets the usable stimulation amplitude in vivo. In vivo, stimulation at high amplitude settings was associated with increased immobility, consistent with effective stimulation through implanted electrodes; electrode impedance and delivered current were not measured in these mice.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Graham, R. D., Creed, M. C., Gaidica, M.. 2026-10-12. FLEX-DBS: a flexible wireless platform for bilateral constant-current deep brain stimulation in freely moving rodents. https://doi.org/10.64898/2026.10.09.757775

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Mesoscale Soft Robotics for Mechanically Perturbing and Functionally Monitoring Responses in Human Organoids

Human organoids represent promising models for studies of significance to the biology and medical communities. Of the existing approaches for monitoring organoids, none offers the ability to apply programmable mechanical forces while simultaneously recording multi-modal physiological responses, of relevance to phenomena spanning from traumatic brain injuries to cardiac rhythm disorders. Here, we present a mesoscale soft robotic organoid interface that enables programmable delivery of forces to organoids of diverse shapes, and to map electrophysiological activity and mechanical responses. The platform combines actuation elements with integrated sensors for quantitative measurement and control. Studies using this technology reveal that spheroidal cortical organoids exhibit distinct responses to mechanical trauma, including silencing, recovery, and changes in neuronal firing patterns. Additional experiments on cardiac ring tissues demonstrate that sustained stretching induces beat-to-beat rhythm variability and altered conduction. The results establish a framework for investigating force-triggered transitions between physiological and disease-like states in human tissue models.

bioengineering↗

Few-shot regulatory sequence design with a genomic language model

A central challenge in generative biology is translating knowledge learned from natural sequences and experiments into designs with desired functions. In-context learning (ICL) is an emergent capability of large language models that allows them to adapt to new tasks from a few examples without additional training, enabling these models to become general-purpose learners. Here, we show that the genome language model, Evo 2, exhibits generative ICL in biological sequence design. Prompting with just tens of examples conditions Evo 2 to generate novel and diverse regulatory DNA sequences without any additional training. Mechanistic analysis suggests that genomic ICL may originate from induction, similar to phenomena observed in natural language. Reinforcement learning leveraging sequence-to-function models as experiment-derived rewards further strengthens ICL. We first validate this approach by generating enhancers that drive cell-type-specific gene expression in three human cell lines. Extending this approach in vivo, enhancers designed using human regulatory element data selectively label layer 5 extratelencephalic neurons in the mouse cortex with high specificity and stronger activity than existing enhancers. Our study provides evidence of emergent properties in genomic sequence models and introduces a promising approach for improving functional conditioning in generative biology.

bioengineering↗

IOP-independent treatment for neurodegeneration in glaucoma using optimized ROS-scavenging microparticles for sustained release of erythropoietin

Glaucoma is a slow-progressing neurodegenerative disease of the optic projection to the brain and a leading cause of blindness worldwide. Current treatments are targeted towards lowering intraocular pressure (IOP), the only known, modifiable risk factor; however, this strategy is ineffective in many patients. An early hallmark of glaucomatous neurodegeneration is increased reactive oxygen species (ROS), representing an alternative opportunity for intervention to halt or slow disease progression. In this work, we optimize a ROS-scavenging copolymer, poly(propylene sulfide-co-ethylene sulfide) (PPSES), for formulation of size-controlled, stabilized, antioxidant microparticles (MPs) for sustained release of the protein erythropoietin (EPO). EPO promotes biological antioxidant defense via activation of NRF2-mediated transcription of antioxidant genes. This MP system overcomes the short half-life of EPO and leverages the combined benefits of bioactive EPO with long-lasting, inherently antioxidant PPSES MPs. The lead EPO-MP formulation preserves neurons in both mouse and non-human primate models of glaucoma through suppression of oxidative stress and optic nerve degeneration. EPO-loaded PPSES MPs represent a translationally relevant therapy for long-term management of glaucoma independent of IOP.

bioengineering↗